# A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction

> **NCT02672267** · PHASE3 · COMPLETED · sponsor: **Altaco XXI, LLP** · enrollment: 50 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **BIOLOGICAL:** Stem cells
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02672267
- **Lead sponsor:** Altaco XXI, LLP
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02672267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02672267, "A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02672267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*